Introduction
Brain pathology and neurodegeneration can result from neurotoxins that enter the brain and from unremoved waste products. The bloodbrain barrier (BBB) keeps out components that may disturb synaptic signaling or generate neurotoxins (Zlokovic, 2008) . In this way, the BBB protects the central nervous system against ion fluctuations that occur in the bloodstream and maintains the homeostasis. Interstitial solutes are transported across the local BBB by transport proteins and are then removed via the blood stream. However, with a large distance between interstitial solutes and the BBB, the water flow regulated by the glial cells must be utilized (Groothuis et al., 2007; Kress et al., 2014) . Cerebrospinal fluid (CSF) is exchanged with interstitial fluid (ISF), facilitated by the aquaporin-4 (AQP4) water channels on the astroglial endfeet. ISF is drained into the paravenous space, from which it eventually reaches the lymphatic nodes. This glymphatic flow can clear solutes from the interstitial space and therefore seems to have the same function as lymph outside the brain. This system was given the name glymphatic system, a merging of the words 'glial' and 'lymphatic' (Iliff et al., 2012) .
BBB breakdown is thought to be the underlying mechanism of small vessel disease, which refers to pathology in the small cerebral blood vessels and capillaries (Wardlaw, 2010; Farrall and Wardlaw, 2009; Kalaria, 2010) . BBB disruption also increases the amount of accumulated amyloid-β protein (Aβ) and Aβ accumulation aggravates BBB disruption (Burgmans et al., 2013) . Aβ is cleared from the brain through BBB transport, but recent studies have demonstrated that its clearance is also largely dependent on the glymphatic system (Kress et al., 2014; Iliff et al., 2012) . The connections between BBB disruption, glymphatic dysfunction and Aβ accumulation could provide a link between vascular pathology and early Alzheimer pathology.
Blood-brain barrier
The BBB in the cerebrovascular wall separates the blood circulation from the brain parenchyma. One component of the BBB are the endothelial cells connected by tight junctions that form a strong physical barrier (Tarasoff-Conway et al., 2015) . The endothelial cells have a luminal membrane at the side of the blood and an abluminal membrane at the side of the parenchyma (Hawkins et al., 2002) . On the abluminal side, the endothelial cells are supported by astrocytes and pericytes . The endothelial cells, astrocytes and pericytes can express enzymes that can inactivate foreign substances that manage to pass through the physical barrier (Abbott et al., 2006) . Only small lipophilic molecules can pass the BBB by means of free diffusion. Furthermore, the BBB contains active transporter proteins and only molecules that match one of these transporters can be actively transferred across the endothelial cells.
The BBB regulates ion transport to keep the ISF optimal for neuronal functioning (Popescu et al., 2009) . The BBB protects the brain from ion fluctuations that occur in the bloodstream after a meal or exercise, which would otherwise disturb synaptic and axonal signaling (Wardlaw et al., 2003) . Moreover, blood components crossing the BBB can activate signaling pathways or trigger inflammatory responses that generate neurotoxins and compromise neuronal functioning (Zlokovic, 2008; Hawkins and Davis, 2005) .
The astrocytes also have an important role in maintaining homeostasis. In normal brain activity, neurons obtain energy through glucose metabolism, which generates water (Abbott et al., 2006) . Water accumulation leads to tissue swelling and excess water must be redistributed. Water passage between the endothelial cells is prevented by the tight junctions (Amiry-Moghaddam and Ottersen, 2003; Nakada et al., 2017) . Transendothelial water transport is limited due to low expression of water channels on the endothelial membrane. The endfeet of the astrocytes, however, contain a high density of AQP4 water channels. Water flow through the AQP4 channels facilitates the redistribution of excess water via the perivascular space.
Blood-brain barrier disruption
Brain pathology often leads to loosening of the tight junctions, which compromises the BBB integrity (Zlokovic, 2008) . It has long been controversial whether BBB disruption is associated with older age, but recently a large-scale meta-analysis of 31 BBB permeability studies has indeed demonstrated that BBB disruption does occur during normal aging (Farrall and Wardlaw, 2009 ). Barnes et al. (2015) found a positive association between BBB leakage in the hippocampus and normal aging (Barnes et al., 2015) . They also demonstrated that BBB leakage in the hippocampus was associated with mild cognitive impairment and concluded that BBB disruption may contribute to dementia onset. A review of BBB permeability studies in dementia concluded that there is increased BBB leakage in individuals with dementia, especially in the presence of white matter hyperintensities and vascular pathology (van de Haar et al., 2014) . Early Alzheimer pathology, such as Aβ accumulation, can further disrupt the BBB (Viggars et al., 2011) .
Aβ is a peptide produced during normal cell metabolism and present in the blood plasma, brain ISF and CSF (Zlokovic, 2004; Haass et al., 1992) . Influx and efflux transport mechanisms regulate the Aβ concentration in the brain. Soluble, unbound Aβ can move across the BBB via receptor-mediated transport (Deane et al., 2004) . Moreover, Aβ carrier proteins can bind and sequester Aβ in the plasma, ISF or CSF (Deane et al., 2004; Hansson et al., 2009) . Carrier proteins forming complexes with Aβ facilitate receptor-mediated transport across the BBB (Zlokovic et al., 1996; Martel et al., 1997) . The blood plasma and extracellular fluid contain Aβ-degrading proteases (Selkoe, 2001) . The Aβ peptide occurs in different forms ranging from 39 to 43 amino acid. Especially unbound Aβ 42 has the tendency to form non-soluble fibrils (24). When the Aβ concentration is high, fibrillary Aβ aggregates, which can lead to accumulation of neurotoxic Aβ plaques. Often in cases of elevated Aβ concentration, changes in Aβ efflux and influx transporters are observed while the amount of Aβ production remains the same (Zlokovic, 2008; Selkoe, 2001) . RAGE is an Aβ influx transporter normally expressed at relatively low levels. LRP1 is the transporter normally involved in the clearance of the Aβ protein across the BBB. The expression of RAGE and LRP1 changes during aging, so that Aβ influx into the brain through RAGE increases, while Aβ efflux from the brain through LRP1 decreases (Shlosberg et al., 2010) . Also members of the ATP-binding cassette (ABC) transporter family are important contributors to the BBB and are involved in the clearance of Aβ across the BBB (Krohn et al., 2011) . For instance, the P-glycoprotein (P-gp) encoded by the ABCB1 gene is highly expressed at the BBB and is involved in Aβ clearance (Cirrito et al., 2005a; van Assema et al., 2012) (Fig. 1b) . P-gp-null mice had significantly higher levels of Aβ in the brain and more Aβ accumulation (Cirrito et al., 2005a) . In humans, studies have demonstrated that AD patients have lower P-gp function relative to healthy controls (van Assema et al., 2012) . Moreover, older subjects demonstrated decreased P-gp function and expression relative to younger subjects (Bartels et al., 2009; Chiu et al., 2015) . Mouse models in which mice were genetically modified to lack specific ABC transporters have demonstrated that more types of ABC transporters are important for Aβ clearance, such as ABCA1 (Koldamova et al., 2014) and ABCC1 (Krohn et al., 2011) .
Dementia research has long focused on the amyloid cascade hypothesis. This hypothesis states that Aβ accumulation in the brain is the Fig. 1 . Overview of a) glymphatic clearance (Tarasoff-Conway et al., 2015) and b) BBB transport adapted with permission from Springer Customer Service Center GmbH: Springer Nature, Nature Reviews Neurology, (Tarasoff-Conway et al., 2015) . direct cause of AD development (Korczyn, 2008) . However, even though the current evidence demonstrates the involvement of Aβ in AD, the available data is not conclusive that it is critical for the development of the disease. As data cannot confirm the amyloid cascade hypothesis, it has repeatedly been suggested that the hypothesis should be restated or even rejected (Herrup, 2015; Kepp, 2017; Behl, 2017) It may be that a third variable exists that could be the cause of AD development and explain the link between AD and Aβ accumulation. A possible candidate is a defective clearance system. Unremoved waste products can compromise BBB integrity and neuronal functioning, which could trigger brain pathology (Zlokovic, 2008) . Aβ is among the waste products that accumulate in the brain due to defective clearance, so that Aβ accumulation coincides with AD development. The brain vasculature plays an important role in clearance, as interstitial solutes are transported across the BBB and removed via the blood stream. Defective clearance as initiating factor of AD blurs the etiological distinction between AD and vascular dementia. Indeed, more researchers now claim that this distinction is not clear-cut (Echávarri et al., 2012; Wardlaw et al., 2013) . AD is usually characterized by Alzheimer pathology, such as Aβ accumulation and tau tangle formation (Jack et al., 2010) . The most common vascular cause of dementia is small vessel disease, which refers to pathology in the small cerebral blood vessels and capillaries (Wardlaw et al., 2013; Pantoni, 2010) . Markers of small vessel disease detected by neuroimaging are for instance white matter lesions, lacunar infarction and microbleeds (Pantoni, 2010) . In reality, disorders lie on a continuum between AD and vascular dementia and the expressed pathology is often a combination between Alzheimer pathology and markers of small vessel disease (Echávarri et al., 2012; Schneider et al., 2007) .
BBB disruption is thought to be one of the underlying mechanism of small vessel disease (Wardlaw, 2010; Farrall and Wardlaw, 2009) . Studies have now also demonstrated that BBB disruption interacts with Aβ accumulation and these processes increase neurodegeneration (Burgmans et al., 2013) . If BBB disruption has a major role in vascular causes of dementia and strengthens Alzheimer pathology, it may be a common trigger for age-related brain pathology (Sironi et al., 2004) . Previously, it was thought that about 75 percent of Aβ was cleared by BBB transport, and only 10 percent by the glymphatic system (Shibata et al., 2000) . However, two recent photon imaging studies in mice, using microscopy with fluorescent tracers, have suggested that the glymphatic system contributes to a larger part of Aβ clearance than previously thought (Kress et al., 2014; Iliff et al., 2012) . Glymphatic dysfunction may provide the link between vascular pathology and Aβ accumulation and lead to new insights on the development of brain pathology.
Glymphatic system
The brain is in a state of constant high metabolic activity and needs an efficient system to remove its metabolites, also those at a larger distance from the BBB (Iliff and Nedergaard, 2013) . This clearance system was named the glymphatic system, due to the involvement of glial cells and its functional resemblance to the lymphatic system (Iliff et al., 2012) .
The perivascular space is the fluid-filled cavity surrounding a penetrating vessel (Wardlaw et al., 2013) . The perivascular space surrounding a penetrating artery (referred to as the para-arterial space by Iliff et al. (2012) ) forms the entrance point of the glymphatic system (Tarasoff-Conway et al., 2015) . CSF runs through the perivascular space on the abluminal side of the endothelial membrane. Perivascular AQP4 channels on the astrocytic endfeet facilitate convective flow of CSF out of the perivascular space into the interstitial space (Iliff et al., 2012; Tarasoff-Conway et al., 2015; Nedergaard, 2013) . Convective flow refers to bulk flow, or movement of a fluid where all components move together at the same speed, so the fluid itself and all that it contains (Hladky and Barrand, 2014) . CSF containing waste products is exchanged with ISF. Convective flow leads ISF with waste products away from the arteries, through the parenchyma and toward the veins into the paravenous space (Iliff et al., 2012; Tarasoff-Conway et al., 2015 ) (Fig. 1 (Tarasoff-Conway et al., 2015 ). Via the paravenous space, ISF with waste products eventually reaches the lymphatic nodes in the neck and enters the lymphatic circulation. Recently, the presence of functional lymphatic vessels in the brain, lining the dural sinuses, has been demonstrated (Louveau et al., 2015) . The researchers propose that the glymphatic system could be the first step of the brain drainage system, in which ISF is drained into the CSF, and as a second step ISF could then enter the newly identified lymphatic vessels in the dura. In mice, a tracer study has already demonstrated that these lymphatic vessels are the major outflow pathway of drainage from the brain . Another possibility is that CSF containing waste products circulates in the arachnoid space and flows through the arachnoid villi to the dural venous sinuses, thereby entering the blood circulation (Tarasoff-Conway et al., 2015; Nedergaard, 2013) . Either through the lymphatic or blood circulation, eventually solutes reach the liver where they are degraded.
Glymphatic dysfunction
Aging is associated with glymphatic dysfunction (Kress et al., 2014) . Glymphatic dysfunction could be due to disregulation of water transport in the astrocytes (Jessen et al., 2015) . The AQP4 channels are responsible for water transport. Mice with AQP4 deletion had impaired CSF influx and lacked a pathway for CSF-to-ISF turnover (Iliff et al., 2012) . Aβ clearance was for instance 55 percent less in these mice. Another study used mice with Aβ-overexpressing mutations (Xu et al., 2015) . AQP4 deletion in these mutant mice lead to significantly higher Aβ levels, while the levels of proteins involved in Aβ formation or degradation remained the same, suggesting it was the clearance that was impaired. The polarization of AQP4 channels seems to be more important than the number of AQP4 channels (Kress et al., 2014) . AQP4 polarization is a measure of relative AQP4 localization, with high polarization meaning high reactivity of the perivascular AQP4 channels relative to the parenchymal AQP4 channels. Depolarization is associated with glymphatic dysfunction in aged mice. Also in the postmortem human brain, AQP4 polarization was found to be a predictor of AD, Aβ level and Braak staging (Zeppenfeld et al., 2017) .
Glymphatic dysfunction could also be due to changes in CSF influx. CSF influx is dependent on arterial pulsatility (Jessen et al., 2015; Iliff et al., 2013a) . In a mice study, dobutamine was used to increase the arterial pulsatility, which lead to increased CSF influx and CSF-to-ISF turnover (Iliff et al., 2013a) . In another study, decreased vessel wall compliance, arterial pulsatility and CSF influx were demonstrated in aged mice (Kress et al., 2014) . However, recent studies have demonstrated that not only inhibition of CSF influx can disrupt glymphatic clearance, but overstimulation of this influx could also be associated with glymphatic dysfunction (Jiang et al., 2017; Mestre et al., 2017) . Enlargement of the perivascular spaces is associated with glymphatic dysfunction (Iliff et al., 2012) . However, this enlargement decreases resistance to the perivascular flow and paradoxically increases CSF influx (Mestre et al., 2017) . Solute trapping in the perivascular space could be a possible explanation for this paradox (Wang et al., 2017) . Increased CSF influx drives more solutes into the perivascular space. However, due to enlargement of perivascular spaces, AQP4 depolarization or changes in the composition of the basal lamina, these solutes cannot leave the perivascular space, combining increased CSF influx with glymphatic dysfunction.
An important consequence of glymphatic dysfunction is that Aβ removal is attenuated. Synaptic activity regulates the amount of Aβ in the interstitial space (Cirrito et al., 2005b) . Aβ is removed again via BBB transport or glymphatic clearance. However, as glymphatic clearance decreases with age, this removal is no longer sufficient, leading to Aβ deposition. Aβ is deposited in the parenchyma, but also in the blood vessel walls as cerebral amyloid angiopathy (CAA) (Roher et al., 2003) . CAA leads to narrowing of the perivascular space and blocks the glymphatic clearance route, which accelerates Aβ accumulation (Nedergaard, 2013; Roher et al., 2003) . This vicious circle of glymphatic dysfunction, protein accumulation and perivascular narrowing may be characteristic for AD (Jessen et al., 2015) .
Glymphatic dysfunction could help us understand neurodegenerative disorders in which accumulation of toxic waste products contributes to disorder development (Wostyn et al., 2015) . Glymphatic dysfunction in rats has already been associated with impaired cognitive functioning on behavioral tests (Jiang et al., 2017; Venkat et al., 2017) . MRI techniques to obtain signal from the perivascular space are being developed and could eventually image glymphatic influx and efflux and the clearance kinetics, which may make it possible to identify those at risk of neurodegenerative disorders such as AD (Iliff et al., 2013b) .
BBB transport and glymphatic clearance seem to have a similar purpose in the removal of interstitial solutes, but still the interaction between these mechanisms has not been clearly discussed previously. Investigating their interplay and their role in brain pathology can add to our knowledge on neurodegenerative disorders and may generate new treatment options. For this narrative review, literature databases were searched for information on waste clearance from the brain, cooperation between the BBB and glymphatic system and the interaction between BBB disruption and glymphatic dysfunction.
Methods
To investigate how the BBB and glymphatic system interact, a literature search was conducted (Grant and Booth, 2009 ). The search terms blood-brain barrier (using MeSH terminology in PubMed and the synonyms blood-brain barriers, blood brain barrier(s), brain-blood barrier (s), brain blood barrier(s), hemato-encephalic barrier(s), hemato encephalic barrier(s) or BBB) and glymphatic were used. The search produced in total 27 results in Embase and 22 results in PubMed. After removing the duplicates, 32 papers remained. Cross-referencing was used.
All 32 papers were screened by reading the abstract and scanning through the main text. Papers were included when they met all of the following inclusion criteria: 1) discussing BBB function, 2) discussing the glymphatic system and 3) specifically focusing on their role in waste clearance. Articles were excluded when they were not available in English, German or Dutch. After screening, 18 papers remained (Fig. 2) . These papers were fully read. All information on waste clearance from the brain, cooperation between the BBB and glymphatic system and the interaction between BBB disruption and glymphatic dysfunction was summarized.
Results

Blood-brain barrier transport and glymphatic clearance as complementary mechanisms
BBB transport and glymphatic clearance have the same purpose in clearing interstitial solutes such as Aβ from the brain and in that sense likely serve complementary roles and seem to be partially overlapping mechanisms (Kress et al., 2014) . As mentioned before, Aβ can be transported across the local BBB by specific efflux transporters such as LRP1 and P-gp (van Assema et al., 2012; Zuroff et al., 2017) . However, the amount of Aβ exceeds the efflux transporter capacity and often the distance to the BBB is too large, so that Aβ must also be cleared through the ISF flow in the glymphatic system (Kress et al., 2014) . The glymphatic system can also stimulate BBB transport as the convective flow spreads Aβ over a wider anatomical area and facilitates BBB transport (Fig. 3) .
Cooperation between BBB transport and the glymphatic system becomes evident when studying their mechanics during the sleep-wake cycle. During wakefulness, the interstitial volume is more contracted, which increases resistance to convective flow and CSF movement (Xie et al., 2013) . During sleep, the interstitial space increases in volume, which facilitates convective flow, CSF-to-ISF turnover and thus glymphatic clearance. It is unclear what causes this increase, but the leading hypothesis is that this is due to sleep-mediated shrinkage of astroglial cells (Mendelsohn and Larrick, 2013) . BBB transport is also partly responsible for the increase in Aβ clearance during sleep (TarasoffConway et al., 2015; Hladky and Barrand, 2017) . Convective flow moves Aβ more toward the BBB, so that BBB transport indirectly increases (Tarasoff-Conway et al., 2015) . Clearance through BBB transport thus increases by mediation of the glymphatic system.
Defective clearance can already be detected before the onset of neuropathology, which suggests that clearance mechanisms have a causal role in neurodegenerative disorders (Peng et al., 2016) . Optimal functioning of clearance mechanisms could thus delay or even prevent the onset of neurodegenerative disorders. Aβ accumulation is for instance present before any symptoms of AD manifest themselves.
Glymphatic dysfunction affecting the blood-brain barrier
The choroid plexus is the organ that secretes CSF. CSF has many functions, like providing buoyancy, nourishment and removal of waste products (Spector et al., 2015) . Formation of the glymphatic circulation is one aspect of the CSF dynamics. Choroid plexus functioning and arterial pulsatility determine the CSF dynamics and for instance regulate CSF influx through the perivascular space and are the driving forces of the glymphatic system (Hladky and Barrand, 2014; Iliff et al., 2013a) . Factors influencing arterial pulsatility, such as vessel stiffness and heart rate, affect the amount of waste clearance (Kyrtsos and Baras, 2015) . Arterial pulsatility decreases due to processes such as metabolic syndrome, hypertension, hyperlipidemia, diabetes or aging. These processes indirectly affect glymphatic clearance and can possibly lead to neurodegeneration. Kress et al. (2014) used in vivo and ex vivo fluorescent imaging with a radiotracer in mice to further investigate the relationship between glymphatic clearance, aterial pulsatility and aging. They demonstrated that Aβ clearance through the glymphatic system decreased by 40 percent in the aged brain relative to a younger brain (Kress et al., 2014) . This decrease was associated with a 27 percent decrease in arterial pulsatility. The cerebral arterial wall is enclosed in the pial sheath and the perivascular astrocytic endfeet sheath. Reactive astrogliosis, or changes in the astrocytes due to central nervous system damage, affects the compliance of these structures and impairs arterial pulsatility. Reactive astrogliosis is also associated with a decrease in perivascular AQP4 channel reactivity at the astrocytic endfeet (Iliff and Nedergaard, 2013) . Both impaired arterial pulsatility and changes in perivascular AQP4 channel reactivity can disturb convective flow and lead to glymphatic dysfunction. As a consequence, Aβ accumulation occurs which can further impair perivascular AQP4 channel reactivity (Yang et al., 2011) . Decrease in perivascular AQP4 channel reactivity, glymphatic dysfunction and Aβ accumulation seem to form a vicious feedforward circle that promotes Aβ accumulation and eventual neurodegeneration (Kress et al., 2014) . Kyrtsos and Baras (2015) created a computer model simulating how Aβ levels change in the brain parenchyma and vasculature under the influence of glymphatic function and apolipoprotein E allele (Kyrtsos and Baras, 2015) . In this model, glymphatic function was defined by heart rate and vessel stiffness. The model demonstrated that lower heart rate was associated with higher Aβ levels in the brain parenchyma. Greater vessel stiffness also led to higher Aβ levels. Moreover, Aβ level did not only increase in the brain parenchyma, but also in the blood vessel walls as the previously mentioned CAA. Especially carriers of the apolipoprotein E4 allele, which is associated with a higher risk of AD (Saunders et al., 1993) , demonstrated CAA.
CAA leads to thickening of the basement membrane, luminal narrowing and narrowing of the perivascular space, which blocks the glymphatic clearance route (Nedergaard, 2013; Roher et al., 2003) . CAA also leads to degeneration of smooth muscle cells and endothelial cells (Saito and Ihara, 2016; Hawkes et al., 2012) . Endothelial cells contain the BBB transport channels and endothelial degeneration disrupts BBB transport. A study in mice has demonstrated that decreasing the amount of endothelial transporters lead to a 55 percent decrease in Aβ clearance (Shibata et al., 2000) . Thus, lower heart rate and greater vessel stiffness affect glymphatic clearance and are associated with cortical Aβ accumulation and CAA. CAA does not only further impair the glymphatic system by perivascular narrowing, but also decreases BBB transport by endothelial degeneration.
3.3. Blood-brain barrier disruption affecting the glymphatic system BBB disruption and inflammation are connected in a vicious circle (Shlosberg et al., 2010) . Defensins are peptides that are released as part of the immune response to defend the brain against pathogens (Kazakos et al., 2017) . Platelet-derived growth factor BB (PDGF-BB) regulates pericyte proliferation and recruitment to ensure microvascular stability. When defensins are expressed on the luminal side of the endothelial membrane, PDGF-BB and defensins compete for the same receptors, which can lead to BBB instability. Moreover, defensins on the luminal side promote the recruitment of mast cells. Mast cells are white blood cells that induce the release of inflammatory mediators leading to BBB disruption. Once in the inflammatory state, reactive oxygen species are released, which affect tight junction integrity and further compromise the BBB (Shlosberg et al., 2010) . Besides BBB disruption, inflammation can also contribute to glymphatic dysfunction. Inflammation slows down the convective flow, decreases CSF-to-ISF turnover and impairs glymphatic clearance (Erickson et al., 2012) . On the abluminal side, inadequate defensin expression can occur, which allows activated Tcells, viruses and inflammatory mediators to enter the brain and impair BBB integrity (Kazakos et al., 2017) . At the same time, glymphatic flow is impeded. Inadequate defensin expression also leads to downregulation of LRP1 and decreased Aβ clearance.
Sleep regulates the immune response and sleep disturbance and inflammation are causally related (He et al., 2014; Aguirre, 2016) . A mouse model of chronic sleep restriction demonstrated that sleep restriction downregulates the expression of tight junction proteins and increases BBB permeability (Pan and Kastin, 2016) . Blood-born substances then freely enter the brain and may trigger excitotoxicity and neuronal death (He et al., 2014) . When these pathological processes impair the AQP4 channels, convective flow is impaired and glymphatic dysfunction occurs (Iliff et al., 2012 . AQP4 channels are part of the astrocytes, which are important for sleep regulation, as increase in astrocytic gene expression and activation of the astrocytes initiate sleep (Aguirre, 2016; Bellesi et al., 2015; Pelluru et al., 2016) . To sum up, inflammation often occurs together with sleep disturbance. Inflammation and sleep disturbance can lead to both BBB disruption and glymphatic dysfunction (Harding et al., 2017) . BBB disruption can also lead to glymphatic dysfunction and aggravate sleep disturbance due to its detrimental effect on the astrocytes.
Investigating glymphatic function using imaging techniques
Practical application of glymphatic function imaging
For the rat brain, a complete map of glymphatic influx and efflux can be constructed using MRI measurements of tracer distribution over the brain. From this map, the clearance kinetics can be derived (Iliff et al., 2013b) . According to Nedergaard (2013) , it is promising to extend this research approach to humans. Defective clearance could be the initiating factor of AD and the clearance kinetics may be used to identify those at risk of AD or evaluate disease progression (Nedergaard, 2013) . Mapping the clearance kinetics could also be used to monitor how a person responds to treatment.
Progress in glymphatic function imaging techniques
The first techniques used to image glymphatic function were in vivo 2-photon microscopy and ex vivo fluorescence imaging of intracisternally infused fluorescent CSF tracers (Iliff et al., 2013b) . However, these techniques are not suitable for clinical practice, due to the complications associated with intracisternal infusion in humans. Previous attempts at cisternal punctures in humans has resulted in acute neurological damage (Keane, 1973) . Lumbar intrathecal infusion is a safer and therefore clinically useful infusion method. Yang et al. (2013) compared the clearance kinetics and tracer distribution in rat brain slices after lumbar intrathecal infusion of CSF tracers (FITCconjugated dextran and Texas Red-conjugated dextran) with the values found after intracisternal infusion (Yang et al., 2013) . The clearance pathway after lumbar intrathecal infusion is consistent with the characterization of the glymphatic system after intracisternal infusion. The researchers concluded that the safer option lumbar intrathecal infusion can be used to investigate activity in the glymphatic system instead of the risky intracisternal infusion. Iliff et al. (2013b) used dynamic contrast-enhanced MRI with intrathecal infusion of contrast agents (Magnevist and GadoSpin) in a vital rat brain (Iliff et al., 2013b) . Contrast agent distribution was used to map the CSF-to-ISF turnover pathway over time and identify the influx nodes and clearance pathways. With this study, Iliff et al. (2013b) laid the groundwork for imaging activity in the glymphatic system with a simple technique suited for clinical practice. They viewed their study as the basis for a new strategy to evaluate AD susceptibility and progression.
After Yang et al. (2013) and Iliff et al. (2013b) mapped tracer distribution in rodent brains, Eide and Ringstad (2015) applied the same approach to the human brain (Eide and Ringstad, 2015) . A woman underwent routine MRI after intrathecal infusion of gadolinium. Gadolinium was widely distributed over the brain and spinal cord, which meant free transport of gadolinium in the CSF and free CSF-to-ISF turnover. Their findings indicated the presence of the glymphatic system, this time in the human brain.
The future of glymphatic function imaging techniques
The glymphatic system starts with CSF flowing through the perivascular space. Future attempts to measure activity in the glymphatic system could focus on imaging the CSF flow within the perivascular space.
Recently, Naganawa et al. (2017) detected contrast agent in the human brain with an imaging technique (heavily T 2 -weighted FLAIR) that is highly sensitive to low gadolinium concentrations in the CSF (Naganawa et al., 2017) . With this technique, researchers were for the first time able to detect signal enhancement in the perivascular space of the human brain, several hours after gadolinium administration (Fig. 4  (Naganawa et al., 2017) ). The perivascular space is an entrance point to the glymphatic system (Kyrtsos and Baras, 2015) . This new imaging technique to visualize gadolinium in the CSF and perivascular space offers a new way to image the clearance pathway through the glymphatic system in humans (Naganawa et al., 2017) .
The same research group also introduced a method to measure water diffusivity along the perivascular space in the human brain, called 'diffusion tensor image analysis along the perivascular space' (DTI-ALPS) . Lower diffusivity along the perivascular space indicates less activity in the glymphatic system and thus less CSF influx and glymphatic dysfunction. DTI-ALPS in 16 AD, nine mild cognitive impairment and six subjective cognitive impairment patients demonstrated a positive correlation between water diffusivity along the perivascular space and Mini-Mental State Examination (MMSE) score. With lower MMSE score and thus more cognitive decline, less activity in the glymphatic system was found. Imaging brain fluid dynamics may help in understanding the pathogenesis of glymphatic dysfunction and early detection of neurodegeneration.
Conclusion
Properly functioning waste clearance systems protect against the accumulation of toxic waste products such as Aβ, and may delay or even prevent the onset of neurodegenerative disorders such as AD. Keeping these clearance systems in good condition could be a new focus of future health initiatives. Many studies into waste clearance emphasize the importance of sleep. Sleep disturbance is linked to inflammation, BBB disruption and glymphatic dysfunction. Adhering to a healthy sleep pattern and daily physical exercise to stimulate cardiovascular health are relatively easy ways to keep the vasculature healthy and improve waste clearance. Voluntary exercise in aged mice increased waste clearance, decreased Aβ level and promoted synaptic integrity (He et al., 2017) . Since there was no association with BBB permeability, it seems likely that the glymphatic system was responsible for the increased clearance. Moreover, mice in the exercise group had better spatial memory, demonstrating that increasing glymphatic clearance by voluntary exercise can improve cognitive functioning.
Techniques to image the glymphatic system continue to be developed, leading to new ways of determining the clearance kinetics. New ways of determining the clearance kinetics may help to identify those at risk of AD or evaluating progression of AD (Nedergaard, 2013) . Moreover, if future health interventions are aimed at improving the clearance kinetics (Ren et al., 2017) , imaging the glymphatic system can be a way to monitor response to this type of treatment. Recent advances are focused on imaging CSF flow or water diffusivity in the perivascular space, thereby attempting to visualize activity in the glymphatic system (Naganawa et al., 2017; Taoka et al., 2017) . A defective clearance system may be the underlying mechanism of age-related brain pathology and new techniques to determine the efficacy of this clearance system may in the future help in identifying who may be vulnerable to age-related cognitive disorders.
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